Navigation Links
Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris
Date:7/9/2008

BIRMINGHAM, Ala., July 9 /PRNewswire/ -- A lawsuit charges pharmaceutical giant Pfizer was motivated by greed when it failed to warn the public of potentially deadly side-effects associated with its popular smoking cessation drug varenicline which is marketed under the trade name Chantix. The suit, brought by the widow of an Indiana man, alleges the decedent committed suicide after using Chantix as prescribed. The victim's tragic death occurred only a few days before the information contained in the drug label and package insert for patients was amended to include warnings for the increased risk of experiencing suicide and similar tragedies. Further, the widow blames Pfizer in the lawsuit by identifying many specific instances of bad conduct, and suggests that Pfizer pursued profit over patient safety.

"This man's death was a direct result of taking the drug Chantix," said Kristian Rasmussen, veteran pharmaceutical litigation attorney with the law firm Cory Watson Crowder & DeGaris. Rasmussen and attorney William E. Winingham of Wilson, Kehoe and Winingham are representing the victim's widow.

The suit says the man was not warned of potentially devastating side effects when he began taking Chantix in October 2007. The man died of a self-inflicted gunshot wound in January, 2008. Less than a month after the Plaintiff committed suicide, Pfizer modified the package insert on Chantix to recommend that all patients being treated with Chantix "be observed for neuropsychiatric symptoms including ... suicidal ideation and suicidal behavior."

"Pfizer's action was too little too late," said Rasmussen. The lawsuit accuses Pfizer of putting profits before patient safety and claims Pfizer failed to report suspected side effects for fear the warnings would cut into sales and profits. Chantix revenues reached $883 million in 2007, according to corporate performance reports available on the company's website. The suit seeks unspecified damages and accuses Pfizer of intentionally, recklessly and or negligently concealing, suppressing, omitting or misrepresenting the risks, dangers, defects and disadvantages of Chantix.

About Cory Watson Crowder & DeGaris

Cory Watson Crowder & DeGaris is recognized nationally for its practice in mass torts litigation, multidistrict litigation and complex litigation including class actions, products liability, business and securities litigation, environmental litigation and mass torts litigation of defective medical devices and pharmaceuticals.


'/>"/>
SOURCE Cory Watson Crowder & DeGaris
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Litigation Predicted in Wake of FAA Ban of Chantix Use by Pilots and Air Traffic Controllers: Smoking Cessation Drug Target of Controversy
2. Road pollution blamed for higher allergy risk in kids
3. People with anorexia less likely to be blamed when biology, genetics explained
4. Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer
5. Antidepressants in suicide prevention
6. As I-1000 Signatures are Counted, Washington State Medical Association Opposition to Physician-Assisted Suicide Reiterated
7. Hope, Volume One, a CD benefiting Suicide Awareness Voices of Education (SAVE), to Be released on June 24, 2008
8. Drink and drugs fuel Scottish suicide and homicide rates
9. Growing Public Health Crisis of Domestic Violence and Suicides by Returning Veterans
10. Californians Against Assisted Suicide - Controversial Bill, AB 2747 Narrowly Passes Assembly
11. VA Secretary Appoints Panel of National Suicide Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... ... launch of its 60-day free trial program for all of the company’s desktop ... offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use an ...
(Date:12/2/2016)... ... ... The annual time frame to change Medicare health and prescription drug coverage, known ... Medicare beneficiaries who are looking to switch from their current plan to a Medicare ... during this period order for their new policy to go into effect in 2017. ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs available ... must find the one that works for them. When an inventor from Suisun City, ... worked and decided to share it with others. , He developed a prototype for ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a leading ... the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The ... education, experience, and professional associations. , One the most frequently honored surgeons ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to announce ... covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients ... life 6 years in the last 3 decades,” says Dr. Valentine Fuster, a ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... MONMOUTH JUNCTION, N.J. , Dec. 2, 2016 /PRNewswire/ ... critical care immunotherapy leader commercializing its European Union approved ... in critically-ill and cardiac surgery patients worldwide, announced that ... present at the 9th Annual LD Micro Main ... 8 th , 2016 at the Luxe Sunset Boulevard ...
(Date:12/2/2016)... LYME, Conn. , Dec. 1, 2016  Today, ... has announced the honor of being selected as winners ... include: Simpson Healthcare Executives Website at the PLATINUM level, ... Conversations Training Module at the GOLD Level, and our ... At Simpson Healthcare Executives, we are excited ...
(Date:12/2/2016)... YORK , December 2, 2016 ... of its past losses following Trump,s victory early in ... potential, and fund managers are now predicting an uptick ... at four equities to see how they have fared ... CLDX ), Amicus Therapeutics Inc. (NASDAQ: ...
Breaking Medicine Technology: